Oakbrook Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,475
Closed -$410K 611
2019
Q2
$410K Buy
3,475
+375
+12% +$37.8K 0.02% 433
2019
Q1
$269K Sell
3,100
-200
-6% -$17K 0.02% 519
2018
Q4
$208K Sell
3,300
-550
-14% -$37.7K 0.01% 543
2018
Q3
$304K Buy
+3,850
New +$251K 0.02% 544

Other funds holding EXAS

Oakbrook Investments's EXAS Position: Q3 2019 in Review

Oakbrook Investments sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 3,475 shares — an estimated $410K sold.

Oakbrook Investments first reported a position in EXAS in Q3 2018 and held it in 4 quarters. The position peaked at $410K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Oakbrook Investments reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
  • Oakbrook Investments sold 3,475 Exact Sciences shares in Q3 2019, an estimated $410K.
  • Oakbrook Investments first reported a position in Exact Sciences in Q3 2018 and held it in 4 quarters.
  • Oakbrook Investments's Exact Sciences position peaked at $410K in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Oakbrook Investments's 13F filing for Q3 2019, filed 18 Oct 2019.